290 related articles for article (PubMed ID: 17254750)
1. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
3. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
4. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
7. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
[TBL] [Abstract][Full Text] [Related]
8. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation.
Kim DJ; Bility MT; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Death Differ; 2006 Jan; 13(1):53-60. PubMed ID: 16021179
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
10. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
[TBL] [Abstract][Full Text] [Related]
11. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM
Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674
[TBL] [Abstract][Full Text] [Related]
12. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
13. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta.
Han S; Ritzenthaler JD; Wingerd B; Roman J
J Biol Chem; 2005 Sep; 280(39):33240-9. PubMed ID: 16061473
[TBL] [Abstract][Full Text] [Related]
15. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
Zhu B; Ferry CH; Blazanin N; Bility MT; Khozoie C; Kang BH; Glick AB; Gonzalez FJ; Peters JM
Oncogene; 2014 Nov; 33(46):5348-59. PubMed ID: 24213576
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335
[TBL] [Abstract][Full Text] [Related]
17. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
18. Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development.
Di-Poï N; Ng CY; Tan NS; Yang Z; Hemmings BA; Desvergne B; Michalik L; Wahli W
Mol Cell Biol; 2005 Mar; 25(5):1696-712. PubMed ID: 15713628
[TBL] [Abstract][Full Text] [Related]
19. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
